Tag: Johnson
J&J Acquires Intra-Cellular Therapies for $14.6B, Expanding Mental Health Drug Portfolio
J&J Acquires Intra-Cellular Therapies for $14.6B, Expanding Mental Health Drug PortfolioIn a groundbreaking move that has sent shockwaves through the pharmaceutical industry, Johnson &...